Commercial Expertise: We provide expert advice on the commercialisation of biotech and MedTech innovations, beyond the Regulatory Clearances, i.e. Health Economics, Reimbursement, Distribution and most importantly Adoption. Med2Mark thoroughly assesses the commercial value of Health-Tech innovations before significant investments are committed. We are selective and engage, for the long run, in projects with strong commercialisation and actual adoption potentials.

Global Experience: We are an international boutique Consulting Practice. Our Advisors come from 7 different countries and are spread over 3 continents. Cumulatively, we have Over 100 years of direct "hands-on" experience in the commercialisation of Biotech and Medtech innovations in the USA, Europe and Australia.

Med2Mark offers an "Executive" engagement model where we embed ourselves in the client organisation at Executive or Board levels, as illustrated by David’s, Attilio’s as well as Pierre’s Executive positions in startups we came across through our consulting activities.